| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,366 |
13,713 |
$940K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,358 |
8,052 |
$396K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,467 |
4,449 |
$269K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,592 |
2,581 |
$233K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,897 |
1,819 |
$51K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,978 |
3,926 |
$49K |
| 87428 |
|
1,422 |
1,395 |
$44K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,935 |
2,726 |
$25K |
| 81002 |
|
2,128 |
2,089 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
136 |
135 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
317 |
307 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
371 |
359 |
$2K |
| 73630 |
|
107 |
107 |
$2K |
| 99406 |
|
214 |
208 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
129 |
81 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
137 |
131 |
$1K |
| 73130 |
|
56 |
56 |
$984.19 |
| 73610 |
|
41 |
41 |
$784.38 |
| 71046 |
Radiologic examination, chest; 2 views |
43 |
43 |
$618.33 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
432 |
424 |
$518.28 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
387 |
381 |
$493.29 |
| 81025 |
|
62 |
60 |
$391.46 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
40 |
40 |
$287.19 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
309 |
301 |
$246.23 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
176 |
172 |
$0.44 |
| 99051 |
|
13 |
13 |
$0.00 |
| 99070 |
|
48 |
47 |
$0.00 |